pindolol has been researched along with Chagas Cardiomyopathy in 2 studies
Pindolol: A moderately lipophilic beta blocker (ADRENERGIC BETA-ANTAGONISTS). It is non-cardioselective and has intrinsic sympathomimetic actions, but little membrane-stabilizing activity. (From Martindale, The Extra Pharmocopoeia, 30th ed, p638)
pindolol : A member of the class of indols which is the 2-hydroxy-3-(isopropylamino)propyl ether derivative of 1H-indol-4-ol.
Chagas Cardiomyopathy: A disease of the CARDIAC MUSCLE developed subsequent to the initial protozoan infection by TRYPANOSOMA CRUZI. After infection, less than 10% develop acute illness such as MYOCARDITIS (mostly in children). The disease then enters a latent phase without clinical symptoms until about 20 years later. Myocardial symptoms of advanced CHAGAS DISEASE include conduction defects (HEART BLOCK) and CARDIOMEGALY.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cremaschi, G | 1 |
| Zwirner, NW | 1 |
| Gorelik, G | 1 |
| Malchiodi, EL | 1 |
| Chiaramonte, MG | 1 |
| Fossati, CA | 1 |
| Sterin-Borda, L | 1 |
| Morris, SA | 1 |
| Barr, S | 1 |
| Weiss, L | 1 |
| Tanowitz, H | 1 |
| Wittner, M | 1 |
| Bilezikian, JP | 1 |
2 other studies available for pindolol and Chagas Cardiomyopathy
| Article | Year |
|---|---|
Modulation of cardiac physiology by an anti-Trypanosoma cruzi monoclonal antibody after interaction with myocardium.
Topics: Animals; Antibodies, Monoclonal; Antibodies, Protozoan; Chagas Cardiomyopathy; Cyclic AMP; Cyclic GM | 1995 |
Myocardial beta-adrenergic adenylate cyclase complex in a canine model of chagasic cardiomyopathy.
Topics: Adenosine Diphosphate Ribose; Adenylyl Cyclases; Animals; Binding, Competitive; Chagas Cardiomyopath | 1991 |